Certive Solutions Inc. (CBP.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | 10.94 Million USD | 12.77% |
| 2021 | 9.7 Million USD | 14.84% |
| 2020 | 8.45 Million USD | 20.85% |
| 2019 | 6.99 Million USD | -0.31% |
| 2018 | 7.01 Million USD | 9.16% |
| 2017 | 6.42 Million USD | 90.98% |
| 2016 | 3.36 Million USD | -41.37% |
| 2015 | 5.73 Million USD | 14.45% |
| 2014 | 5.01 Million USD | 546.24% |
| 2013 | 776.04 Thousand USD | -31.12% |
| 2012 | 1.12 Million USD | 312.81% |
| 2011 | 272.92 Thousand USD | 1893.15% |
| 2010 | 13.69 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q2 | 11.84 Million USD | 2.98% |
| 2023 Q3 | 12.24 Million USD | 3.43% |
| 2023 Q1 | 11.5 Million USD | 5.07% |
| 2022 FY | 10.94 Million USD | 12.77% |
| 2022 Q3 | 10.95 Million USD | 4.12% |
| 2022 Q4 | 10.94 Million USD | -0.07% |
| 2022 Q1 | 10.14 Million USD | 4.54% |
| 2022 Q2 | 10.52 Million USD | 3.68% |
| 2021 Q3 | 9.58 Million USD | 6.32% |
| 2021 Q4 | 9.7 Million USD | 1.26% |
| 2021 Q1 | 8.95 Million USD | 5.96% |
| 2021 FY | 9.7 Million USD | 14.84% |
| 2021 Q2 | 9.01 Million USD | 0.67% |
| 2020 Q3 | 8.09 Million USD | 6.4% |
| 2020 Q1 | 7.57 Million USD | 8.24% |
| 2020 Q2 | 7.61 Million USD | 0.53% |
| 2020 FY | 8.45 Million USD | 20.85% |
| 2020 Q4 | 8.45 Million USD | 4.38% |
| 2019 Q4 | 6.99 Million USD | 0.84% |
| 2019 Q1 | 7.87 Million USD | 12.23% |
| 2019 Q2 | 8.71 Million USD | 10.73% |
| 2019 FY | 6.99 Million USD | -0.31% |
| 2019 Q3 | 6.93 Million USD | -20.45% |
| 2018 Q3 | 8.25 Million USD | 8.66% |
| 2018 FY | 7.01 Million USD | 9.16% |
| 2018 Q4 | 7.01 Million USD | -15.05% |
| 2018 Q2 | 7.6 Million USD | 7.48% |
| 2018 Q1 | 7.07 Million USD | 10.03% |
| 2017 Q2 | 4.62 Million USD | 14.47% |
| 2017 Q1 | 4.03 Million USD | 20.04% |
| 2017 FY | 6.42 Million USD | 90.98% |
| 2017 Q4 | 6.42 Million USD | 28.4% |
| 2017 Q3 | 5 Million USD | 8.25% |
| 2016 Q4 | 3.36 Million USD | -1.25% |
| 2016 Q2 | 3.27 Million USD | -50.62% |
| 2016 FY | 3.36 Million USD | -41.37% |
| 2016 Q1 | 6.63 Million USD | 15.51% |
| 2016 Q3 | 3.4 Million USD | 4.08% |
| 2015 Q4 | 5.73 Million USD | 7.69% |
| 2015 FY | 5.73 Million USD | 14.45% |
| 2015 Q2 | 5.8 Million USD | 0.9% |
| 2015 Q3 | 5.32 Million USD | -8.15% |
| 2015 Q1 | 5.75 Million USD | 14.68% |
| 2014 Q2 | 5.33 Million USD | 22.65% |
| 2014 Q4 | 5.01 Million USD | -30.4% |
| 2014 Q3 | 7.2 Million USD | 35.15% |
| 2014 Q1 | 4.34 Million USD | 460.21% |
| 2014 FY | 5.01 Million USD | 546.24% |
| 2013 Q4 | 776.04 Thousand USD | -63.24% |
| 2013 Q3 | 2.11 Million USD | 47.48% |
| 2013 Q2 | 1.43 Million USD | 18.9% |
| 2013 Q1 | 1.2 Million USD | 6.87% |
| 2013 FY | 776.04 Thousand USD | -31.12% |
| 2012 FY | 1.12 Million USD | 312.81% |
| 2012 Q1 | 780.2 Thousand USD | 185.87% |
| 2012 Q2 | 911.05 Thousand USD | 16.77% |
| 2012 Q3 | 1.02 Million USD | 12.94% |
| 2012 Q4 | 1.12 Million USD | 9.49% |
| 2011 Q3 | 378.35 Thousand USD | 67.15% |
| 2011 FY | 272.92 Thousand USD | 1893.15% |
| 2011 Q4 | 272.92 Thousand USD | -27.87% |
| 2011 Q1 | 116.1 Thousand USD | 747.92% |
| 2011 Q2 | 226.35 Thousand USD | 94.96% |
| 2010 FY | 13.69 Thousand USD | 0.0% |
| 2010 Q2 | 5218.14 USD | 0.0% |
| 2010 Q4 | 13.69 Thousand USD | 59.1% |
| 2010 Q3 | 8606.34 USD | 64.93% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AI/ML Innovations Inc. | 1.53 Million CAD | -610.927% |
| Diagnamed Holdings Corp. | 426.38 Thousand CAD | -2467.152% |
| Pangenomic Health Inc. | 2.21 Million CAD | -393.927% |
| nDatalyze Corp. | 38.26 Thousand CAD | -28509.049% |
| Treatment.Com International Inc. | 1.47 Million CAD | -640.905% |
| Unidoc Health Corp. | 2.38 Million CAD | -359.827% |